Search clinical trials for: MEDI0639

Total 6 results

MedImmune LLC

Completed

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors

Solid Tumors

United States
MedImmune LLC

Completed

Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas

Relapsed/Refractory Aggressive B-cell Lymphomas

United States
MedImmune LLC

Completed

A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies

Advanced Malignancies

United States
AstraZeneca

Completed

A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Chronic Pain

Germany
AstraZeneca

Completed

Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Chronic Pain

Germany
MedImmune LLC

Completed

A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

Kidney Cancer | Clear Cell Renal Cell Carcinoma | Select Advanced Malignancies

United States, France, Canada, United Kingdom, Netherlands, Australia

3

Subscribe